JPWO2019210181A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019210181A5 JPWO2019210181A5 JP2020560228A JP2020560228A JPWO2019210181A5 JP WO2019210181 A5 JPWO2019210181 A5 JP WO2019210181A5 JP 2020560228 A JP2020560228 A JP 2020560228A JP 2020560228 A JP2020560228 A JP 2020560228A JP WO2019210181 A5 JPWO2019210181 A5 JP WO2019210181A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- item
- nucleic acid
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091033319 polynucleotide Proteins 0.000 claims description 68
- 102000040430 polynucleotide Human genes 0.000 claims description 68
- 239000002157 polynucleotide Substances 0.000 claims description 68
- 150000007523 nucleic acids Chemical class 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 40
- 102000039446 nucleic acids Human genes 0.000 claims description 39
- 108020004707 nucleic acids Proteins 0.000 claims description 39
- 239000013598 vector Substances 0.000 claims description 39
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 29
- 210000002768 hair cell Anatomy 0.000 claims description 27
- 206010011878 Deafness Diseases 0.000 claims description 15
- 231100000895 deafness Toxicity 0.000 claims description 13
- 208000016354 hearing loss disease Diseases 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 230000001225 therapeutic effect Effects 0.000 claims description 9
- 230000001720 vestibular Effects 0.000 claims description 9
- 108700019146 Transgenes Proteins 0.000 claims description 6
- 230000004064 dysfunction Effects 0.000 claims description 6
- 108091006252 SLC8A2 Proteins 0.000 claims description 4
- 102100038538 Sodium/calcium exchanger 2 Human genes 0.000 claims description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 208000009205 Tinnitus Diseases 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 231100000886 tinnitus Toxicity 0.000 claims description 3
- APHFXDBDLKPMTA-UHFFFAOYSA-N 2-(3-decanoyl-4,5,7-trihydroxynaphthalen-2-yl)acetic acid Chemical compound CCCCCCCCCC(=O)c1c(CC(O)=O)cc2cc(O)cc(O)c2c1O APHFXDBDLKPMTA-UHFFFAOYSA-N 0.000 claims description 2
- 102100030374 Actin, cytoplasmic 2 Human genes 0.000 claims description 2
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 2
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 2
- 101150115448 CABP2 gene Proteins 0.000 claims description 2
- 102100022509 Cadherin-23 Human genes 0.000 claims description 2
- 102100032220 Calcium and integrin-binding family member 2 Human genes 0.000 claims description 2
- 102100032213 Calcium and integrin-binding family member 3 Human genes 0.000 claims description 2
- 102100030049 Calcium-binding protein 2 Human genes 0.000 claims description 2
- 101710163595 Chaperone protein DnaK Proteins 0.000 claims description 2
- 102100031060 Clarin-1 Human genes 0.000 claims description 2
- 102100031052 Clarin-2 Human genes 0.000 claims description 2
- 102100036631 Coiled-coil domain-containing glutamate-rich protein 2 Human genes 0.000 claims description 2
- 102100023583 Cyclic AMP-dependent transcription factor ATF-6 alpha Human genes 0.000 claims description 2
- 102100023945 Dynein light chain Tctex-type 5 Human genes 0.000 claims description 2
- 102000020045 EPS8 Human genes 0.000 claims description 2
- 108091016436 EPS8 Proteins 0.000 claims description 2
- 102100030013 Endoribonuclease Human genes 0.000 claims description 2
- 102100035218 Epidermal growth factor receptor kinase substrate 8-like protein 2 Human genes 0.000 claims description 2
- 102100031809 Espin Human genes 0.000 claims description 2
- 102100031808 Espin-like protein Human genes 0.000 claims description 2
- 102100034174 Eukaryotic translation initiation factor 2-alpha kinase 3 Human genes 0.000 claims description 2
- 102100038522 Fascin-2 Human genes 0.000 claims description 2
- 102100040646 Fc receptor-like B Human genes 0.000 claims description 2
- 102100024405 GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Human genes 0.000 claims description 2
- 102100023697 Glutaredoxin domain-containing cysteine-rich protein 1 Human genes 0.000 claims description 2
- 102100023695 Glutaredoxin domain-containing cysteine-rich protein 2 Human genes 0.000 claims description 2
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims description 2
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims description 2
- 101710113864 Heat shock protein 90 Proteins 0.000 claims description 2
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 claims description 2
- 102100021888 Helix-loop-helix protein 1 Human genes 0.000 claims description 2
- 101000773237 Homo sapiens Actin, cytoplasmic 2 Proteins 0.000 claims description 2
- 101000899442 Homo sapiens Cadherin-23 Proteins 0.000 claims description 2
- 101000943456 Homo sapiens Calcium and integrin-binding family member 2 Proteins 0.000 claims description 2
- 101000943458 Homo sapiens Calcium and integrin-binding family member 3 Proteins 0.000 claims description 2
- 101000992973 Homo sapiens Clarin-1 Proteins 0.000 claims description 2
- 101000992978 Homo sapiens Clarin-2 Proteins 0.000 claims description 2
- 101000715266 Homo sapiens Coiled-coil domain-containing glutamate-rich protein 2 Proteins 0.000 claims description 2
- 101000905751 Homo sapiens Cyclic AMP-dependent transcription factor ATF-6 alpha Proteins 0.000 claims description 2
- 101000904021 Homo sapiens Dynein light chain Tctex-type 5 Proteins 0.000 claims description 2
- 101001010783 Homo sapiens Endoribonuclease Proteins 0.000 claims description 2
- 101000876686 Homo sapiens Epidermal growth factor receptor kinase substrate 8-like protein 2 Proteins 0.000 claims description 2
- 101000920837 Homo sapiens Espin Proteins 0.000 claims description 2
- 101000920839 Homo sapiens Espin-like protein Proteins 0.000 claims description 2
- 101001030534 Homo sapiens Fascin-2 Proteins 0.000 claims description 2
- 101000892451 Homo sapiens Fc receptor-like B Proteins 0.000 claims description 2
- 101000981252 Homo sapiens GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 claims description 2
- 101000829459 Homo sapiens Glutaredoxin domain-containing cysteine-rich protein 1 Proteins 0.000 claims description 2
- 101000829452 Homo sapiens Glutaredoxin domain-containing cysteine-rich protein 2 Proteins 0.000 claims description 2
- 101000897691 Homo sapiens Helix-loop-helix protein 1 Proteins 0.000 claims description 2
- 101001047085 Homo sapiens Kielin/chordin-like protein Proteins 0.000 claims description 2
- 101001091571 Homo sapiens Kinocilin Proteins 0.000 claims description 2
- 101100181435 Homo sapiens LCE6A gene Proteins 0.000 claims description 2
- 101001020452 Homo sapiens LIM/homeobox protein Lhx3 Proteins 0.000 claims description 2
- 101001004836 Homo sapiens Leucine-rich repeat and transmembrane domain-containing protein 2 Proteins 0.000 claims description 2
- 101001043326 Homo sapiens Lipoxygenase homology domain-containing protein 1 Proteins 0.000 claims description 2
- 101001120869 Homo sapiens MKRN2 opposite strand protein Proteins 0.000 claims description 2
- 101000635935 Homo sapiens Myosin-IIIa Proteins 0.000 claims description 2
- 101000583016 Homo sapiens Myosin-IIIb Proteins 0.000 claims description 2
- 101000822093 Homo sapiens Neuronal acetylcholine receptor subunit alpha-9 Proteins 0.000 claims description 2
- 101001134169 Homo sapiens Otoferlin Proteins 0.000 claims description 2
- 101001094737 Homo sapiens POU domain, class 4, transcription factor 3 Proteins 0.000 claims description 2
- 101001001817 Homo sapiens Pejvakin Proteins 0.000 claims description 2
- 101000610652 Homo sapiens Peripherin-2 Proteins 0.000 claims description 2
- 101000591234 Homo sapiens Phosphatidylinositol phosphatase PTPRQ Proteins 0.000 claims description 2
- 101000728125 Homo sapiens Plasma membrane calcium-transporting ATPase 2 Proteins 0.000 claims description 2
- 101000728117 Homo sapiens Plasma membrane calcium-transporting ATPase 4 Proteins 0.000 claims description 2
- 101001049860 Homo sapiens Potassium voltage-gated channel subfamily A member 10 Proteins 0.000 claims description 2
- 101001072259 Homo sapiens Protocadherin-15 Proteins 0.000 claims description 2
- 101001110308 Homo sapiens Radixin Proteins 0.000 claims description 2
- 101000591236 Homo sapiens Receptor-type tyrosine-protein phosphatase R Proteins 0.000 claims description 2
- 101000664381 Homo sapiens SKI family transcriptional corepressor 1 Proteins 0.000 claims description 2
- 101000836388 Homo sapiens Serpin E3 Proteins 0.000 claims description 2
- 101000585180 Homo sapiens Stereocilin Proteins 0.000 claims description 2
- 101000713234 Homo sapiens TRIO and F-actin-binding protein Proteins 0.000 claims description 2
- 101000801710 Homo sapiens Taperin Proteins 0.000 claims description 2
- 101000701142 Homo sapiens Transcription factor ATOH1 Proteins 0.000 claims description 2
- 101000801040 Homo sapiens Transmembrane channel-like protein 1 Proteins 0.000 claims description 2
- 101000740765 Homo sapiens Voltage-dependent calcium channel subunit alpha-2/delta-4 Proteins 0.000 claims description 2
- 101000804908 Homo sapiens Xin actin-binding repeat-containing protein 2 Proteins 0.000 claims description 2
- 101000916503 Homo sapiens Zinc finger CCHC domain-containing protein 12 Proteins 0.000 claims description 2
- 101001059220 Homo sapiens Zinc finger protein Gfi-1 Proteins 0.000 claims description 2
- 101000982323 Human herpesvirus 8 type P (isolate GK18) Complement control protein Proteins 0.000 claims description 2
- 102100022808 Kielin/chordin-like protein Human genes 0.000 claims description 2
- 102100035796 Kinocilin Human genes 0.000 claims description 2
- 102100036106 LIM/homeobox protein Lhx3 Human genes 0.000 claims description 2
- 102100024569 Late cornified envelope protein 6A Human genes 0.000 claims description 2
- 102100025969 Leucine-rich repeat and transmembrane domain-containing protein 2 Human genes 0.000 claims description 2
- 102100021959 Lipoxygenase homology domain-containing protein 1 Human genes 0.000 claims description 2
- 102100026053 MKRN2 opposite strand protein Human genes 0.000 claims description 2
- 102100030743 Myosin-IIIa Human genes 0.000 claims description 2
- 102100030369 Myosin-IIIb Human genes 0.000 claims description 2
- 102100021520 Neuronal acetylcholine receptor subunit alpha-9 Human genes 0.000 claims description 2
- 108090000742 Neurotrophin 3 Proteins 0.000 claims description 2
- 102100034198 Otoferlin Human genes 0.000 claims description 2
- 108091008010 PERKs Proteins 0.000 claims description 2
- 102100035398 POU domain, class 4, transcription factor 3 Human genes 0.000 claims description 2
- 102100036328 Pejvakin Human genes 0.000 claims description 2
- 102100040375 Peripherin-2 Human genes 0.000 claims description 2
- 102100029743 Plasma membrane calcium-transporting ATPase 4 Human genes 0.000 claims description 2
- 102100023066 Potassium voltage-gated channel subfamily A member 10 Human genes 0.000 claims description 2
- 102100036382 Protocadherin-15 Human genes 0.000 claims description 2
- 102100022127 Radixin Human genes 0.000 claims description 2
- 101100135885 Rattus norvegicus Pdia4 gene Proteins 0.000 claims description 2
- 102100034101 Receptor-type tyrosine-protein phosphatase R Human genes 0.000 claims description 2
- 102100038524 SKI family transcriptional corepressor 1 Human genes 0.000 claims description 2
- 108091006282 SLC17A8 Proteins 0.000 claims description 2
- 102100027290 Serpin E3 Human genes 0.000 claims description 2
- 102100032889 Sortilin Human genes 0.000 claims description 2
- 102100029924 Stereocilin Human genes 0.000 claims description 2
- 102100036855 TRIO and F-actin-binding protein Human genes 0.000 claims description 2
- 102100033600 Taperin Human genes 0.000 claims description 2
- 102100029373 Transcription factor ATOH1 Human genes 0.000 claims description 2
- 102100033690 Transmembrane channel-like protein 1 Human genes 0.000 claims description 2
- 102100038033 Vesicular glutamate transporter 3 Human genes 0.000 claims description 2
- 102100037053 Voltage-dependent calcium channel subunit alpha-2/delta-4 Human genes 0.000 claims description 2
- 102100036955 Xin actin-binding repeat-containing protein 2 Human genes 0.000 claims description 2
- -1 ZCCTC12 Proteins 0.000 claims description 2
- 102100028878 Zinc finger CCHC domain-containing protein 12 Human genes 0.000 claims description 2
- 102100029004 Zinc finger protein Gfi-1 Human genes 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 claims description 2
- 238000011069 regeneration method Methods 0.000 claims description 2
- 210000003030 auditory receptor cell Anatomy 0.000 description 6
- 230000005779 cell damage Effects 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000004307 hair cells vestibular Anatomy 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 239000013607 AAV vector Substances 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 210000000067 inner hair cell Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000199 ototoxic Toxicity 0.000 description 2
- 230000002970 ototoxic effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 241001655883 Adeno-associated virus - 1 Species 0.000 description 1
- 241000702423 Adeno-associated virus - 2 Species 0.000 description 1
- 241000202702 Adeno-associated virus - 3 Species 0.000 description 1
- 241000580270 Adeno-associated virus - 4 Species 0.000 description 1
- 241001634120 Adeno-associated virus - 5 Species 0.000 description 1
- 241000972680 Adeno-associated virus - 6 Species 0.000 description 1
- 241001164823 Adeno-associated virus - 7 Species 0.000 description 1
- 241001164825 Adeno-associated virus - 8 Species 0.000 description 1
- 241000649045 Adeno-associated virus 10 Species 0.000 description 1
- 241000649046 Adeno-associated virus 11 Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011882 Deafness congenital Diseases 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 206010033109 Ototoxicity Diseases 0.000 description 1
- 208000019467 X-linked deafness Diseases 0.000 description 1
- 201000006795 X-linked nonsyndromic deafness Diseases 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 201000006797 autosomal dominant nonsyndromic deafness Diseases 0.000 description 1
- 208000036201 autosomal recessive hearing loss Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- AVOLMBLBETYQHX-UHFFFAOYSA-N etacrynic acid Chemical compound CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl AVOLMBLBETYQHX-UHFFFAOYSA-N 0.000 description 1
- 229960003199 etacrynic acid Drugs 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 231100000262 ototoxicity Toxicity 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023130016A JP7686709B2 (ja) | 2018-04-27 | 2023-08-09 | ミオシン１５プロモーター及びその使用 |
| JP2025084732A JP2025122095A (ja) | 2018-04-27 | 2025-05-21 | ミオシン１５プロモーター及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862663679P | 2018-04-27 | 2018-04-27 | |
| US62/663,679 | 2018-04-27 | ||
| PCT/US2019/029366 WO2019210181A1 (en) | 2018-04-27 | 2019-04-26 | Myosin 15 promoters and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023130016A Division JP7686709B2 (ja) | 2018-04-27 | 2023-08-09 | ミオシン１５プロモーター及びその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021521842A JP2021521842A (ja) | 2021-08-30 |
| JPWO2019210181A5 true JPWO2019210181A5 (https=) | 2022-05-09 |
| JP2021521842A5 JP2021521842A5 (https=) | 2022-05-09 |
| JP7331011B2 JP7331011B2 (ja) | 2023-08-22 |
Family
ID=68294246
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560228A Active JP7331011B2 (ja) | 2018-04-27 | 2019-04-26 | ミオシン１５プロモーター及びその使用 |
| JP2023130016A Active JP7686709B2 (ja) | 2018-04-27 | 2023-08-09 | ミオシン１５プロモーター及びその使用 |
| JP2025084732A Pending JP2025122095A (ja) | 2018-04-27 | 2025-05-21 | ミオシン１５プロモーター及びその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023130016A Active JP7686709B2 (ja) | 2018-04-27 | 2023-08-09 | ミオシン１５プロモーター及びその使用 |
| JP2025084732A Pending JP2025122095A (ja) | 2018-04-27 | 2025-05-21 | ミオシン１５プロモーター及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12233136B2 (https=) |
| JP (3) | JP7331011B2 (https=) |
| CN (3) | CN119410636A (https=) |
| AU (1) | AU2019257782B2 (https=) |
| CA (1) | CA3098198A1 (https=) |
| WO (1) | WO2019210181A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019530737A (ja) | 2016-08-23 | 2019-10-24 | アコーオス インコーポレイテッド | ヒト対象において非加齢性聴力障害を治療するための組成物および方法 |
| US11660353B2 (en) | 2018-04-27 | 2023-05-30 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| WO2020123713A1 (en) * | 2018-12-11 | 2020-06-18 | Decibel Therapeutics, Inc. | Compositions and methods for the delivery of therapeutic agents across the round window membrane |
| EP3921032A4 (en) | 2019-02-08 | 2022-11-30 | Decibel Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS |
| AU2020218547A1 (en) | 2019-02-08 | 2021-08-26 | Decibel Therapeutics, Inc. | Myosin 15 promoters and uses thereof |
| CA3159549A1 (en) | 2019-10-30 | 2021-05-06 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| EP4054653A4 (en) * | 2019-11-04 | 2023-11-29 | Decibel Therapeutics, Inc. | PROMOTERS OF COCHLEAR EXTERNAL HAIR CELLS AND THEIR USES |
| EP4055175A4 (en) | 2019-11-04 | 2023-11-29 | Decibel Therapeutics, Inc. | Cochlear inner hair cell promoters and uses thereof |
| JP7807380B2 (ja) | 2020-02-21 | 2026-01-27 | アコーオス インコーポレイテッド | ヒト対象において非加齢関連聴力障害を処置するための組成物および方法 |
| WO2021222682A1 (en) * | 2020-04-30 | 2021-11-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Application of aav44.9 vector in gene therapy for the inner ear |
| US20250114480A1 (en) * | 2022-01-25 | 2025-04-10 | Bridgebio Gene Therapy Research, Inc. | Gene therapy for genetic hearing loss |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9720465D0 (en) | 1997-09-25 | 1997-11-26 | Oxford Biomedica Ltd | Dual-virus vectors |
| US6436392B1 (en) | 1998-05-20 | 2002-08-20 | University Of Iowa Research Foundation | Adeno-associated virus vectors |
| WO1999064627A2 (en) * | 1998-06-06 | 1999-12-16 | Genostic Pharma Limited | Probes used for genetic profiling |
| EP1224313A1 (en) | 1999-10-07 | 2002-07-24 | University of Iowa Research Foundation | Adeno-associated viruses and uses thereof |
| WO2001029243A1 (en) | 1999-10-15 | 2001-04-26 | Dalhousie University | Method and vector for producing and transferring trans-spliced peptides |
| US20040072154A1 (en) | 2000-12-22 | 2004-04-15 | Morris David W. | Novel compositions and methods for cancer |
| JP2003088388A (ja) | 2001-09-14 | 2003-03-25 | Herikkusu Kenkyusho:Kk | 新規な全長ｃＤＮＡ |
| US20070161031A1 (en) | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
| US8298818B2 (en) | 2006-04-28 | 2012-10-30 | University Of Florida Research Foundation, Inc. | Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter |
| JP5575486B2 (ja) | 2007-01-18 | 2014-08-20 | ユニヴァーシティ オブ ミズーリー−コロンビア | 筋鞘にｎＮＯＳを回復させる合成ミニ／ミクロジストロフィン遺伝子 |
| FR2919305B1 (fr) | 2007-07-26 | 2009-09-18 | Genethon Ass Loi De 1901 | Vecteurs viraux adeno-associes pour l'expression de la dysferline. |
| EP2732819B1 (en) * | 2008-02-07 | 2019-10-16 | Massachusetts Eye & Ear Infirmary | Compounds that enhance Atoh-1 expression |
| US8236557B2 (en) | 2008-05-28 | 2012-08-07 | University Of Missouri-Columbia | Hybrid-AAV vectors to deliver large gene expression cassette |
| US8962314B2 (en) | 2008-11-26 | 2015-02-24 | The Regents Of The University Of California | Lateral ventricle cell compositions and use for treating neural degenerative diseases |
| HRP20190144T1 (hr) | 2010-04-23 | 2019-03-22 | University Of Florida Research Foundation, Inc. | Pripravci raav-gvanilat ciklaze i postupci za liječenje leberove urođene amauroze-1 (lca1) |
| KR20140047141A (ko) * | 2011-08-03 | 2014-04-21 | 쿠아크 파마수티칼스 인코퍼레이티드 | 청력 및 균형 장애를 치료하기 위한 이중-가닥 올리고뉴클레오티드 화합물들 |
| WO2013075008A1 (en) | 2011-11-16 | 2013-05-23 | University Of Florida Research Foundation Inc. | Aav dual vector systems for gene therapy |
| EP2802657B1 (en) * | 2012-01-12 | 2018-05-02 | Quark Pharmaceuticals, Inc. | Combination therapy for treating hearing and balance disorders |
| AU2013249202B2 (en) | 2012-04-18 | 2018-08-09 | The Children's Hospital Of Philadelphia | Composition and methods for highly efficient gene transfer using AAV capsid variants |
| CA2884309A1 (en) | 2012-09-07 | 2014-03-13 | Massachusetts Eye And Ear Infirmary | Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity |
| CA2909733C (en) | 2013-04-18 | 2023-10-17 | Fondazione Telethon | Effective delivery of large genes by dual aav vectors |
| KR102234672B1 (ko) | 2013-05-21 | 2021-04-06 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 |
| US10751385B2 (en) | 2015-02-20 | 2020-08-25 | Institut Pasteur | Prevention and/or treatment of hearing loss or impairment |
| RS63416B1 (sr) | 2015-03-03 | 2022-08-31 | Fond Telethon | Sistem višestrukih vektora i njegove primene |
| SG11201804814YA (en) * | 2015-12-11 | 2018-07-30 | Massachusetts Eye & Ear Infirmary | Materials and methods for delivering nucleic acids to cochlear and vestibular cells |
| WO2017108931A1 (en) | 2015-12-22 | 2017-06-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Improved hybrid dual recombinant aav vector systems for gene therapy |
| JP2019530737A (ja) | 2016-08-23 | 2019-10-24 | アコーオス インコーポレイテッド | ヒト対象において非加齢性聴力障害を治療するための組成物および方法 |
| WO2018145111A1 (en) | 2017-02-06 | 2018-08-09 | Children's Medical Center Corporation | Materials and methods for delivering nucleic acids to cochlear and vestibular cells |
| AU2018261769B2 (en) | 2017-05-05 | 2024-03-14 | The Regents Of The University Of California | Compositions and methods for expressing Otoferlin |
| DE102018103924A1 (de) | 2018-02-21 | 2019-08-22 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Gentherapeutische Behandlung von Schwerhörigkeit |
| IL325122A (en) | 2018-02-22 | 2026-02-01 | Akouos Inc | Compositions and methods for treating non-age-related hearing impairment in humans |
| US11660353B2 (en) | 2018-04-27 | 2023-05-30 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| US12188041B2 (en) | 2018-11-01 | 2025-01-07 | University Of Florida Research Foundation, Incorporated | Codon optimized otoferlin AAV dual vector gene therapy |
| CN118497276A (zh) | 2018-11-07 | 2024-08-16 | 阿库斯股份有限公司 | 腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途 |
| JP2022522995A (ja) | 2019-01-18 | 2022-04-21 | ボイジャー セラピューティクス インコーポレイテッド | Ａａｖ粒子を生成するための方法及びシステム |
| WO2020148458A1 (en) | 2019-01-18 | 2020-07-23 | Institut Pasteur | Aav-mediated gene therapy restoring the otoferlin gene |
| EP3921032A4 (en) | 2019-02-08 | 2022-11-30 | Decibel Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS |
| AU2020218547A1 (en) | 2019-02-08 | 2021-08-26 | Decibel Therapeutics, Inc. | Myosin 15 promoters and uses thereof |
| CA3159549A1 (en) | 2019-10-30 | 2021-05-06 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| CN117295529A (zh) | 2021-02-19 | 2023-12-26 | 分贝治疗公司 | 使用耳畸蛋白双载体系统治疗感觉神经性听力损失的方法 |
-
2019
- 2019-04-26 CN CN202411557776.3A patent/CN119410636A/zh active Pending
- 2019-04-26 CA CA3098198A patent/CA3098198A1/en active Pending
- 2019-04-26 WO PCT/US2019/029366 patent/WO2019210181A1/en not_active Ceased
- 2019-04-26 US US17/050,741 patent/US12233136B2/en active Active
- 2019-04-26 JP JP2020560228A patent/JP7331011B2/ja active Active
- 2019-04-26 CN CN201980042739.XA patent/CN112703016B/zh active Active
- 2019-04-26 AU AU2019257782A patent/AU2019257782B2/en active Active
- 2019-04-26 CN CN202411557780.XA patent/CN119410637A/zh active Pending
-
2023
- 2023-08-09 JP JP2023130016A patent/JP7686709B2/ja active Active
-
2025
- 2025-01-17 US US19/027,519 patent/US20250319205A1/en active Pending
- 2025-05-21 JP JP2025084732A patent/JP2025122095A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521842A5 (https=) | ||
| CA2909733C (en) | Effective delivery of large genes by dual aav vectors | |
| US8257969B2 (en) | Genetic suppression and replacement | |
| JP7655700B2 (ja) | 選択的遺伝子治療発現系 | |
| CN109844124B (zh) | 年龄相关疾病和病症的基因治疗方法 | |
| JP2025000750A5 (https=) | ||
| JP2021512649A5 (https=) | ||
| JP2021532812A5 (https=) | ||
| JPWO2019210181A5 (https=) | ||
| JP2020509786A5 (https=) | ||
| JP2017529395A5 (https=) | ||
| JPWO2020163761A5 (https=) | ||
| JPWO2019153009A5 (https=) | ||
| JP2021533801A5 (https=) | ||
| JP2018533976A5 (https=) | ||
| CN117867025A (zh) | ScAAV-DJ/8装载的精炼凝血因子IX载体的制备及用途 | |
| JP7537762B2 (ja) | 改変ノイラミニダーゼ | |
| JPWO2020038473A5 (https=) | ||
| WO2024094009A1 (zh) | 用于目的基因的表达盒及其应用 | |
| JPWO2019241624A5 (https=) | ||
| JPWO2021076941A5 (https=) | ||
| JP2026513145A (ja) | 標的遺伝子の発現カセット及びその応用 | |
| HK40104471A (zh) | 用於目的基因的表达盒及其应用 | |
| CN119220539A (zh) | Gjb2启动子序列及其载体和应用 | |
| WO2024240095A1 (zh) | 用于治疗补体旁路相关疾病的aav载体 |